
AKARI THERAPEUTICS PLC-ADR
AKTXNASDAQ๐ #3863 by market capEarnings Aug 18US Equity
$7.73โฒ $0.21 (+2.66%)
๐ After hours$7.73โฒ 0.00%Regular close ยท extended-hours price shown1hโ
24hโฒ 2.7%
7dโฒ 3.3%
14dโผ 8.5%
30dโผ 46.5%
1yโผ 82.1%
๐ฆMarket Cap
$27.59B
Mid Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
47
Weak
Earnings
Q2 ยท 2026Reported 2026-05-19Earnings Per Share
Actual
-9.74
Expected
-1.33
miss
โ632.30%
YoY โ7114.80%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q2 2026
-9.74
miss
Q2 2026
-2.99
miss
Q4 2025
-4.00
miss
Q3 2025
-0.06
beat